Other Species / Isoforms
  F3 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
N43
TNTVAAYNLTWKSTN
0 1
F3 (human) TNTVAAYNLTWKSTN N43
F3 (mouse) GIPEKAFnLTWISTD N37-ng
F3 (rat) TPPGKAFNLTWISTD N38
N63
EWEPKPVNQVYTVQI
0 1
F3 (human) EWEPKPVNQVYTVQI N63
F3 (mouse) EWQPKPTnYTYTVQI N57-ng
F3 (rat) EWQPKPTNYTYTVQI N58
K100-ub
DEIVKDVkQTYLARV
0 1
F3 (human) DEIVKDVkQTYLARV K100-ub
F3 (mouse) DEIVKDVTWAYEAKV T94
F3 (rat) DEIVKDVNWTYEARV N95
-
gap
0 1
F3 (human) gap -
F3 (mouse) LSVPRRNsVHGDGDQ S109-p
F3 (rat) LSVPWRNSTHGKETL S110
S120-p
GNVESTGsAGEPLYE
0 1
F3 (human) GNVESTGsAGEPLYE S120-p
F3 (mouse) NsVHGDGDQLVIHGE D115
F3 (rat) NSTHGKETLFGTHGE T116
N169
ERTLVRRNNTFLSLR
0 1
F3 (human) ERTLVRRNNTFLSLR N169
F3 (mouse) SLTLVRKnGtFLtLR N169-ng
F3 (rat) SFTLVRKNGTFLTLR N170
T171
TLVRRNNTFLSLRDV
0 1
F3 (human) TLVRRNNTFLSLRDV T171
F3 (mouse) TLVRKnGtFLtLRQV T171-p
F3 (rat) TLVRKNGTFLTLRQV T172
S174
RRNNTFLSLRDVFGK
0 1
F3 (human) RRNNTFLSLRDVFGK S174
F3 (mouse) RKnGtFLtLRQVFGK T174-p
F3 (rat) RKNGTFLTLRQVFGN T175
S227
SVQAVIPSRTVNRKS
0 1
F3 (human) SVQAVIPSRTVNRKS S227
F3 (mouse) FVQAMIFsRKTNQNS S227-p
F3 (rat) FAQAVIFSRKTNHKS S228
G247
ECMGQEKGEFREIFY
1 0
F3 (human) ECMGQEKGEFREIFY G247
F3 (mouse) VCTEQWKsFLGETLI S247-p
F3 (rat) KCTEQWKSVLGETLI S248
S285-p
RKAGVGQsWkENsPL
Upstream
Downstream
9 0
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
  • phosphorylation
  • protein conformation
  • ubiquitination
Effects on Biological Processes:
  • apoptosis, altered
  • cell growth, altered
  • cell motility, altered
Kinase, in vitro:
  • P38A (human)
Phosphatases, in vitro:
  • PPP2CA (human)
Putative in vivo kinases:
  • PKCA (human)
Treatment
  • calyculin_A
  • Go_6976
  • Go_6983
  • hispidin
  • PAR2-activating_peptide
  • peptide_agonist
  • safingol
  • thrombin
view more >
F3 (human) RKAGVGQsWkENsPL S285-p
F3 (mouse) RKNRAGQKGKNTPSR K285
F3 (rat) RKNRAGQKRKNTPSR K286
K287-ub
AGVGQsWkENsPLNV
Downstream
1 5
Effects on Modified Protein
  • phosphorylation
  • ubiquitination
Effects on Biological Processes:
  • endocytosis, induced
F3 (human) AGVGQsWkENsPLNV K287-ub
F3 (mouse) NRAGQKGKNTPSRLA K287
F3 (rat) KNRAGQKRKNTPSRL R287
K287-m1
AGVGQsWkENsPLNV
0 1
F3 (human) AGVGQsWkENsPLNV K287-m1
F3 (mouse) NRAGQKGKNTPSRLA K287
F3 (rat) KNRAGQKRKNTPSRL R287
S290-p
GQsWkENsPLNVs__
Upstream
Downstream
11 1
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
  • phosphorylation
  • protein conformation
  • ubiquitination
Effects on Biological Processes:
  • cell growth, altered
  • cell motility, altered
Kinase, in vitro:
  • P38A (human)
Putative in vivo kinases:
  • P38A (human)
  • PKCA (human)
Treatment
  • brefeldin_A
  • GF109203X
  • Go_6976
  • Go_6983
  • hispidin
  • methyl-beta-cyclodextrin
  • palmitate
  • PAR2-activating_peptide
  • peptide_agonist
  • phorbol_ester
  • rottlerin
  • safingol
  • SB202190
  • thrombin
view more >
F3 (human) GQsWkENsPLNVs__ S290-p
F3 (mouse) AGQKGKNTPSRLA__ T289
F3 (rat) AGQKRKNTPSRLA__ T290
S295-p
ENsPLNVs_______
Downstream
1 0
Effects on Biological Processes:
  • cell motility, altered
F3 (human) ENsPLNVs_______ S295-p
F3 (mouse) KNTPSRLA_______ A294
F3 (rat) KNTPSRLA_______ A295